Literature DB >> 17266384

Medicaid preferred drug lists: cost containment and side effects.

Alvin E Headen1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17266384     DOI： 10.2165/00019053-200624003-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  6 in total

1.  Preferred drug lists and Medicaid prescriptions.

Authors:  Tamer Abdelgawad; Lisa Egbuonu-Davis
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Effects of medicaid access restrictions on statin utilisation for patients treated by physicians practising in poor and minority neighbourhoods.

Authors:  Alvin E Headen; Neal A Masia; Kirsten J Axelsen
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Impact of Medicaid preferred drug lists on therapeutic adherence.

Authors:  David B Ridley; Kirsten J Axelsen
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives?

Authors:  Jonathan D Ketcham; Andrew J Epstein
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  The effect of using newer drugs on admissions of elderly Americans to hospitals and nursing homes: state-level evidence from 1997 to 2003.

Authors:  Frank R Lichtenberg
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  Per-patient-per-month drug costs in Medicare Part D protected classes.

Authors:  Lisa Mucha; Neal A Masia; Kirsten J Axelsen
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.